• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Xpert® MTB/RIF即时检测实施的影响:产品创新与流程创新

Impact of point-of-care implementation of Xpert® MTB/RIF: product vs. process innovation.

作者信息

Schumacher S G, Thangakunam B, Denkinger C M, Oliver A A, Shakti K B, Qin Z Z, Michael J S, Luo R, Pai M, Christopher D J

机构信息

McGill University Department of Epidemiology & Biostatistics, Montreal, Canada; McGill International TB Centre, Montreal, Quebec, Canada.

Department of Pulmonary Medicine, Christian Medical College Vellore, India.

出版信息

Int J Tuberc Lung Dis. 2015 Sep;19(9):1084-90. doi: 10.5588/ijtld.15.0120.

DOI:10.5588/ijtld.15.0120
PMID:26260830
Abstract

BACKGROUND

Both product innovation (e.g., more sensitive tests) and process innovation (e.g., a point-of-care [POC] testing programme) could improve patient outcomes.

OBJECTIVE

To study the respective contributions of product and process innovation in improving patient outcomes.

DESIGN

We implemented a POC programme using Xpert(®) MTB/RIF in an out-patient clinic of a tertiary care hospital in India. We measured the impact of process innovation by comparing time to diagnosis with routine testing vs. POC testing. We measured the impact of product innovation by comparing accuracy and time to diagnosis using smear microscopy vs. POC Xpert.

RESULTS

We enrolled 1012 patients over a 15-month period. Xpert had high accuracy, but the incremental value of one Xpert over two smears was only 6% (95%CI 3-12). Implementing Xpert as a routine laboratory test did not reduce the time to diagnosis compared to smear-based diagnosis. In contrast, the POC programme reduced the time to diagnosis by 5.5 days (95%CI 4.3-6.7), but required dedicated staff and substantial adaptation of clinic workflow.

CONCLUSION

Process innovation by way of a POC Xpert programme had a greater impact on time to diagnosis than the product per se, and can yield important improvements in patient care that are complementary to those achieved by introducing innovative technologies.

摘要

背景

产品创新(如更灵敏的检测方法)和流程创新(如即时检测[POC]项目)均可能改善患者预后。

目的

研究产品创新和流程创新在改善患者预后方面各自的作用。

设计

我们在印度一家三级护理医院的门诊实施了一项使用Xpert(®)MTB/RIF的即时检测项目。我们通过比较常规检测与即时检测的诊断时间来衡量流程创新的影响。我们通过比较涂片显微镜检查与即时检测Xpert的准确性和诊断时间来衡量产品创新的影响。

结果

在15个月期间,我们纳入了1012例患者。Xpert具有较高的准确性,但与两张涂片相比,一次Xpert检测的增加值仅为6%(95%可信区间3-12)。与基于涂片的诊断相比,将Xpert作为常规实验室检测并未缩短诊断时间。相比之下,即时检测项目使诊断时间缩短了5.5天(95%可信区间4.3-6.7),但需要专门的工作人员并对门诊工作流程进行大幅调整。

结论

通过即时检测Xpert项目进行的流程创新对诊断时间的影响比产品本身更大,并且可以在患者护理方面产生重要改善,这与引入创新技术所取得的改善相辅相成。

相似文献

1
Impact of point-of-care implementation of Xpert® MTB/RIF: product vs. process innovation.Xpert® MTB/RIF即时检测实施的影响:产品创新与流程创新
Int J Tuberc Lung Dis. 2015 Sep;19(9):1084-90. doi: 10.5588/ijtld.15.0120.
2
Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial.南非开普敦重症监护病房的结核病负担,以及对 Xpert MTB/RIF 检测在诊断肺结核方面的准确性及其对患者结局影响的评估:一项采用嵌套随机对照试验的疾病负担前瞻性研究。
Lancet Respir Med. 2015 Aug;3(8):621-30. doi: 10.1016/S2213-2600(15)00198-8. Epub 2015 Jul 22.
3
Added value of molecular assay Xpert MTB/RIF compared to sputum smear microscopy to assess the risk of tuberculosis transmission in a low-prevalence country.分子检测 Xpert MTB/RIF 比痰涂片显微镜检查在低流行国家评估结核病传播风险的附加价值。
Clin Microbiol Infect. 2016 Jul;22(7):613-9. doi: 10.1016/j.cmi.2016.04.010. Epub 2016 Apr 29.
4
Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial.在非洲基层医疗环境中使用即时 Xpert MTB/RIF 检测进行结核病检测的可行性、准确性和临床效果:一项多中心、随机、对照试验。
Lancet. 2014 Feb 1;383(9915):424-35. doi: 10.1016/S0140-6736(13)62073-5. Epub 2013 Oct 28.
5
Impact of the Xpert(®) MTB/RIF molecular test on the late diagnosis of pulmonary tuberculosis.Xpert(®)MTB/RIF分子检测对肺结核延迟诊断的影响。
Int J Tuberc Lung Dis. 2014 Apr;18(4):435-7. doi: 10.5588/ijtld.13.0747.
6
Evaluation of the Xpert MTB/RIF assay at a tertiary care referral hospital in a setting where tuberculosis and HIV infection are highly endemic.在结核病和艾滋病高度流行的环境中,对一家三级保健转诊医院的 Xpert MTB/RIF 检测进行评估。
Clin Infect Dis. 2012 Nov;55(9):1171-8. doi: 10.1093/cid/cis631. Epub 2012 Jul 17.
7
Routine use of Xpert® MTB/RIF in areas with different prevalences of HIV and drug-resistant tuberculosis.在艾滋病毒和耐药结核病患病率不同的地区常规使用Xpert® MTB/RIF。
Int J Tuberc Lung Dis. 2015 Sep;19(9):1078-83, i-iii. doi: 10.5588/ijtld.14.0951.
8
Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study.在撒哈拉以南非洲地区,采用 Xpert MTB/RIF 检测法对胃抽吸物进行检测诊断儿童结核病的评估:一项前瞻性描述性研究。
Lancet Infect Dis. 2013 Jan;13(1):36-42. doi: 10.1016/S1473-3099(12)70245-1. Epub 2012 Nov 5.
9
Xpert(®) MTB/RIF assay for the diagnosis of pulmonary tuberculosis in children.用于诊断儿童肺结核的Xpert(®) MTB/RIF检测
Int J Tuberc Lung Dis. 2016 Jun;20(6):839-43. doi: 10.5588/ijtld.15.0824.
10
The patient impact of point-of-care vs. laboratory placement of Xpert(®) MTB/RIF.即时检测(POC)与实验室放置的Xpert(®)MTB/RIF对患者的影响
Int J Tuberc Lung Dis. 2015 Jul;19(7):811-6. doi: 10.5588/ijtld.15.0013.

引用本文的文献

1
Finding the missed millions: innovations to bring tuberculosis diagnosis closer to key populations.寻找遗漏的数百万人:推动结核病诊断更贴近重点人群的创新举措。
BMC Glob Public Health. 2024 May 17;2(1):33. doi: 10.1186/s44263-024-00063-4.
2
[Limitations of the Xpert-MTB/RIF® assay in the initial diagnosis of tuberculosis in the context of a rural hospital in Ethiopia].[Xpert-MTB/RIF®检测法在埃塞俄比亚一家农村医院结核病初始诊断中的局限性]
Rev Esp Quimioter. 2022 Dec;35(6):559-562. doi: 10.37201/req/052.2022. Epub 2022 Sep 22.
3
Validation of Differentially Expressed Immune Biomarkers in Latent and Active Tuberculosis by Real-Time PCR.
实时 PCR 法对潜伏性和活动性结核病差异表达免疫生物标志物的验证。
Front Immunol. 2021 Mar 16;11:612564. doi: 10.3389/fimmu.2020.612564. eCollection 2020.
4
Guidance for Studies Evaluating the Accuracy of Sputum-Based Tests to Diagnose Tuberculosis.评价基于痰液检测诊断结核病准确性的研究指南。
J Infect Dis. 2019 Oct 8;220(220 Suppl 3):S99-S107. doi: 10.1093/infdis/jiz258.
5
TB treatment delay associated with drug resistance and admission at Daru General Hospital in Papua New Guinea.巴布亚新几内亚达鲁综合医院与耐药性及入院相关的结核病治疗延误
Public Health Action. 2019 Sep 21;9(Suppl 1):S50-S56. doi: 10.5588/pha.18.0075.
6
Surrogate endpoints in global health research: still searching for killer apps and silver bullets?全球卫生研究中的替代终点:仍在寻找杀手级应用和万灵药吗?
BMJ Glob Health. 2018 Mar 8;3(2):e000755. doi: 10.1136/bmjgh-2018-000755. eCollection 2018.
7
"Before Xpert I only had my expertise": A qualitative study on the utilization and effects of Xpert technology among pediatricians in 4 Indian cities.“在 Xpert 之前,我只有自己的专业知识”:一项在印度 4 个城市的儿科医生中评估 Xpert 技术应用和效果的定性研究。
PLoS One. 2018 Mar 16;13(3):e0193656. doi: 10.1371/journal.pone.0193656. eCollection 2018.
8
Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe.GeneXpert 平台检测 HIV 和 TB 多疾病:津巴布韦农村的可行性研究。
PLoS One. 2018 Mar 2;13(3):e0193577. doi: 10.1371/journal.pone.0193577. eCollection 2018.
9
Impact of Point-of-Care Xpert MTB/RIF on Tuberculosis Treatment Initiation. A Cluster-randomized Trial.即时检测Xpert MTB/RIF对结核病治疗启动的影响。一项整群随机试验。
Am J Respir Crit Care Med. 2017 Oct 1;196(7):901-910. doi: 10.1164/rccm.201702-0278OC.
10
Why being an expert - despite xpert -remains crucial for children in high TB burden settings.为何即便存在“专家”(xpert)一词,成为专家对于结核病高负担地区的儿童而言仍然至关重要。
BMC Infect Dis. 2017 Feb 6;17(1):123. doi: 10.1186/s12879-017-2236-9.